LDE225 for Patients With PTCH1 or SMO Mutated Tumors
Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this signal seeking study is to determine whether treatment with LDE225
demonstrates sufficient efficacy in hedgehog pathway-mutated solid tumors and/or hematologic
malignancies to warrant further study